Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 9, 2015
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amarantus Bioscience Holdings, Inc.
| 200K |
$0.05 | $9,980.00 | +150.00% | 333.33K |
Apr 9
| |||||||
Amarantus Bioscience Holdings, Inc.
| 133.33K |
$0.08 | $9,999.98 |
∞
| 133.33K |
Nov 19
| |||||||
Amarantus Bioscience Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Biovest International Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Bionovo Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 17
| |||||||
Bionovo Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Titan Pharmaceuticals Inc
| 200K |
—
|
—
| +165.86% | 320.58K |
Oct 21
| |||||||
Titan Pharmaceuticals Inc
| 9K |
$1.61 | $14,490.00 | +8.07% | 120.58K |
Jan 3 - Jan 4
| |||||||
Titan Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Titan Pharmaceuticals Inc
| 15.5K |
$2.14 | $33,170.00 | +16.13% | 111.58K |
Apr 27
| |||||||
Titan Pharmaceuticals Inc
| 26K |
$2.38 | $61,837.00 | +37.10% | 96.08K |
Mar 20
| |||||||
Titan Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Titan Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Sep 21
| |||||||
Titan Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Sep 18
| |||||||
Titan Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Titan Pharmaceuticals Inc
| 24K |
$1.67 | $40,005.00 | +50.23% | 71.78K |
Oct 13 - Oct 17
| |||||||
Titan Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 7
| |||||||
Titan Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 9
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||